AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Lincoff, AM Kereiakes, DJ Mascelli, MA Deckelbaum, LI Barnathan, ES Patel, KK Frederick, B Nakada, MT Topol, EJ
Citation: Am. Lincoff et al., Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization, CIRCULATION, 104(2), 2001, pp. 163-167

Authors: Molino, M Woolkalis, MJ Prevost, N Pratico, D Barnathan, ES Taraboletti, G Haggarty, BS Hesselgesser, J Horuk, R Hoxie, JA Brass, LF
Citation: M. Molino et al., CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2, BBA-MOL BAS, 1500(2), 2000, pp. 227-240

Authors: Coulter, SA Cannon, CP Ault, KA Antman, EM Van de Werf, F Adgey, AJJ Gibson, CM Giugliano, RP Mascelli, MA Scherer, J Barnathan, ES Braunwald, E Kleiman, NS
Citation: Sa. Coulter et al., High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction - Results from TIMI (thrombolysis in myocardial infarction) 14, CIRCULATION, 101(23), 2000, pp. 2690-2695

Authors: Kariko, K Kuo, A Barnathan, ES
Citation: K. Kariko et al., Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA, GENE THER, 6(6), 1999, pp. 1092-1100

Authors: Chang, AW Kuo, A Barnathan, ES Okada, SS
Citation: Aw. Chang et al., Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase, ART THROM V, 18(12), 1998, pp. 1855-1860
Risultati: 1-5 |